Evolution of erythromycin resistance in Streptococcus pneumoniae in Italy

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 2, 2005, Pages 256-259

  Monaco, Monica ^a   Camilli, Romina ^a   D'Ambrosio, Fabio ^a   Del Grosso, Maria ^a   Pantosti, Annalisa ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

erm(B); Macrolides; mef(A); Molecular typing

Indexed keywords

CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; GENOTYPE; ITALY; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; EVOLUTION, MOLECULAR; HUMANS; ITALY; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 14744300924     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh551     Document Type: Article

References (12)

1. EARSS Annual Report 2002. (2003). [Online.] http://www.earss. rivm.nl (20 September 2004, date last accessed).
2. Tait-Kamradt, A., Davies, T., Cronan, M. et al. (2000). Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrobial Agents and Chemotherapy 44, 2118-25.
3. Santagati, M., Iannelli, F., Oggioni, M. et al. (2000). Characterization of a genetic element carrying the macrolide efflux gene mef(A) in Streptococcus, pneumoniae. Antimicrobial Agents and Chemotherapy 44, 2585-7.
4. Gay, K. & Stephens, D. (2001). Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae. Journal of Infectious Diseases 184, 56-65.
5. Del Grosso, M., Iannelli, F., Messina, C. et al. (2002). Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae. Journal of Clinical Microbiology 40, 774-8.
6. Farrell, D., Morrissey, I., Bakker, S. et al. (2004). Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm(B)- and mef(A)-mediated macrolide resistance. Journal of Clinical Microbiology 42, 764-8.
7. Pantosti, A., Boccia, D., D'Ambrosio, F. et al. (2003). Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of isolates from invasive diseases. Microbial Drug Resistance 9, S61-8.
8. Dicuonzo, G., Gherardi, G., Gertz, R. E. et al. (2002). Genotypes of invasive pneumococcal isolates recently recovered from Italian patients. Journal of Clinical Microbiology 40, 3660-5.
9. National Committee for Clinical Laboratory Standards. (2002). Performance Standards for Antimicrobial Susceptibility Testing; Twelfth Informational Supplement M100-S12. NCCLS, Wayne, PA, USA.
10. Pantosti, A., D'Ambrosio, F., Bordi, E. et al. (2001). Activity of quinupristin-dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy. Clinical Microbiology and Infection 7, 503-6.
11. Farrell, D. J., Douthwaite, S., Morrissey, I. et al. (2003). Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study. Antimicrobial Agents and Chemotherapy 47, 1777-83.
12. Enright, M. C. & Spratt, B. G. (1998). A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144, 3049-60.